GlaxoSmithKline PLC (OTC Pink - Current Information:GLAXF)

20.84
Delayed Data
As of Feb 24
 -0.55 / -2.55%
Today’s Change
19.09
Today|||52-Week Range
24.20
-11.79%
Year-to-Date
Teva Pharmaceutical Gets a Taste of Its Own Medicine As the FDA Approves a Generic of Its Asthma Drug
Feb 24 / MotleyFool.com - Paid Partner Content
FDA Approved 1,014 Generic Drugs in 2019
Feb 19 / MotleyFool.com - Paid Partner Content
GlaxoSmithKline Signs COVID-19 Collaboration Deal With Clover Biopharmaceuticals
Feb 24 / MotleyFool.com - Paid Partner Content
Is Dynavax Technologies Stock a Buy?
Feb 19 / MotleyFool.com - Paid Partner Content
Better Buy: GlaxoSmithKline vs. Eli Lilly
Feb 23 / MotleyFool.com - Paid Partner Content
FDA Approves 3 Drugs for the Switch From Prescription to Over the Counter
Feb 17 / MotleyFool.com - Paid Partner Content
FDA's Advisory Committee to Review Claims That GlaxoSmithKline's Trelegy Ellipta Reduces Mortality
Feb 21 / MotleyFool.com - Paid Partner Content
3 Top Dividend Stocks With Yields Over 5%
Feb 17 / MotleyFool.com - Paid Partner Content
A Plan to Use Blockchain to Stop Counterfeit Drugs Moves Forward
Feb 21 / MotleyFool.com - Paid Partner Content
Better Buy: GlaxoSmithKline vs. Bristol-Myers Squibb
Feb 16 / MotleyFool.com - Paid Partner Content
Merck's Chief Digital Officer Leaves to Join Marriott
Feb 20 / MotleyFool.com - Paid Partner Content
Why Theravance Biopharma Shares Are Sinking Today
Feb 12 / MotleyFool.com - Paid Partner Content
GlaxoSmithKline Signs Potential $600 Million-Plus Cancer Immunotherapy Research-Partnership Deal
Feb 20 / MotleyFool.com - Paid Partner Content